12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Flucelvax regulatory update

FDA approved seasonal influenza vaccine Flucelvax from Novartis to prevent influenza subtypes A and type B in adults. Flucelvax is the first seasonal influenza vaccine approved in the...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >